Medical News

RSS

MID completes enrollment in STASIS trial of Permaseal

Micro Interventional Devices, Inc. has completed enrollment in its Secure Transapical Access and Closure Study. STASIS is a non-randomized, multi-center, CE-Mark study, evaluating the safety and performance of Permaseal the world's first automated direct myocardial ventricular access and closure technology especially designed for use in transcatheter valve replacement procedures (TAVR and TMVR).

11 Jan 2015

Precision NanoSystems, Arcturus Therapeutics partner to develop RNA medicines

Precision NanoSystems, a leader in the development and application of microfluidics for the manufacture of nanomedicines; and, Arcturus Therapeutics, a leading small interfering RNA (siRNA) and messenger RNA (mRNA) drug discovery and development company, today announced a partnership for the manufacture of RNA medicines.

From Precision NanoSystems Inc. 11 Jan 2015

Gaumard provides update on installations of Victoria birthing simulators in the U.S.

Gaumard Scientific Company today provided an update on installations of the Victoria birthing simulator at U.S. health care educational facilities.

11 Jan 2015

Baylor Scott & White Health to build sports medicine facility at The Star – Home of the Dallas Cowboys

Baylor Scott & White Health is working towards the construction of a 200,000 square-foot center of excellence for sports medicine at The Star – Home of the Dallas Cowboys in Frisco, Texas.

11 Jan 2015

Hikma prepares to launch colchicine 0.6mg capsules in the US market

Hikma Pharmaceuticals PLC, the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. has been unsuccessful in appealing the decision by the United States District Court for the District of Delaware to deny Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine 0.6mg capsules for the prophylaxis of gout flares in adults.

11 Jan 2015

Two leading biotechnology companies collaborate to gain further understanding of Parkinson’s disease

This week 23andMe (a genetic testing company) and Genentech (medical research company of the Roche Group) agreed a collaboration to undertake whole genome sequencing for 3,000 patients with Parkinson’s disease. The genetic information will be collected by 23andMe and used by Genentech to identify new therapeutic targets for treating Parkinson’s disease.

9 Jan 2015

NCCN collaborates with Flatiron Health to create oncology outcomes database

The National Comprehensive Cancer Network is collaborating with Flatiron Health to create a cloud-based data repository of NCCN Member Institution data - the NCCN Outcomes Database.

9 Jan 2015

A good night's sleep linked to better academic performance in children

Making sure school-aged kids get to sleep at a regular hour is often a struggle for parents. But a study by researchers at McGill University and the Douglas Mental Health University Institute in Montreal suggests it's well worth the effort: the researchers found that a good night's sleep is linked to better performance in math and languages - subjects that are powerful predictors of later learning and academic success.

9 Jan 2015

Personal gender identity of every human being is reflected in the structure of brain networks

Our sense of belonging to the male or female gender is an inherent component of the human identity perception. As a general rule, gender identity and physical sex coincide. If this is not the case, one refers to trans-identity or transsexuality. In a current study, brain researcher Georg S. Kanz of the University Clinic for Psychiatry and Psychotherapy of the MedUni Vienna was able to demonstrate that the very personal gender identity of every human being is reflected and verifiable in the cross-links between brain regions.

9 Jan 2015

Nuo signs licensing and distribution agreement with Rohto for Aurix wound care system

Nuo Therapeutics, Inc., a pioneer in biodynamic therapies, today announced that it has signed an exclusive licensing and distribution agreement for the Aurix System with Rohto Pharmaceutical Co., Ltd., one of Japan’s leading pharmaceutical, health and wellness companies.

9 Jan 2015

Orlando Regional Medical Center opens new patient tower

As the new year begins, Orlando Health turns the page to a new chapter in patient, guest and team member experience, when Orlando Regional Medical Center opens its new patient tower.

9 Jan 2015

DiaCarta raises $8 million in Series A financing from BVCF

DiaCarta, Inc., a privately-held biotechnology company raised $8 million in Series A financing from BVCF (BioVeda China Fund). Proceeds from Series A financing will be used to expand the product portfolio and support global commercialization. Dr. Weixin Xu of BVCF will join DiaCarta board of directors.

9 Jan 2015

Yeast-eating gut bacteria can help battle bowel problems and autoimmune diseases

Human gut bacteria that feast on the yeast contained in fermented foods like bread and beer provides clues to new treatments for people suffering from bowel diseases.

9 Jan 2015

Sustained quality improvement changes in ICU benefits both patients and health care facility

In a pre- and post-evaluation study, Johns Hopkins Medicine researchers found that quality improvement changes made in an intensive care unit (ICU) were still in practice five years later — benefiting both patients and the health care facility. Those changes included new protocols for treating critically ill patients by encouraging early physical therapy in the ICU.

9 Jan 2015

Tribology and testing of orthopaedic implants white paper published by Lucideon

Lucideon, the international materials development and testing company, has published a new white paper, ‘Tribology and Testing of Orthopaedic Implants’.

From Lucideon 9 Jan 2015

CHLA scientists grow tissue-engineered small intestine from human cells

A new study by researchers at Children's Hospital Los Angeles has shown that tissue-engineered small intestine grown from human cells replicates key aspects of a functioning human intestine. The tissue-engineered small intestine they developed contains important elements of the mucosal lining and support structures, including the ability to absorb sugars, and even tiny or ultra-structural components like cellular connections.

9 Jan 2015

Crown Bioscience to double capacity of PRECOS facility, rename UK site

Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced that it will double the capacity of the recently acquired PRECOS (Preclinical Oncology Services Limited) facility and will rename the site Crown Bioscience UK Ltd.

9 Jan 2015

Medical News

MID completes enrollment in STASIS trial of Permaseal

Precision NanoSystems, Arcturus Therapeutics partner to develop RNA medicines

Gaumard provides update on installations of Victoria birthing simulators in the U.S.

Baylor Scott & White Health to build sports medicine facility at The Star – Home of the Dallas Cowboys

Hikma prepares to launch colchicine 0.6mg capsules in the US market

Two leading biotechnology companies collaborate to gain further understanding of Parkinson’s disease

NCCN collaborates with Flatiron Health to create oncology outcomes database

A good night's sleep linked to better academic performance in children

Personal gender identity of every human being is reflected in the structure of brain networks

Nuo signs licensing and distribution agreement with Rohto for Aurix wound care system

Orlando Regional Medical Center opens new patient tower

DiaCarta raises $8 million in Series A financing from BVCF

Yeast-eating gut bacteria can help battle bowel problems and autoimmune diseases

Sustained quality improvement changes in ICU benefits both patients and health care facility

Tribology and testing of orthopaedic implants white paper published by Lucideon

CHLA scientists grow tissue-engineered small intestine from human cells

Crown Bioscience to double capacity of PRECOS facility, rename UK site

Some medicines can make skin sun-sensitive, says NPS MedicineWise clinical adviser

Increased UV radiation can affect human fertility, new NTNU study finds

Two new ODYSSEY trials meet primary efficacy endpoints

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News